Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot/Phase I Study of Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

NCT06014905 is registered in ClinicalTrials.gov with Charlie Wang, MD, PhD as lead sponsor.

NCT NCT06014905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06014905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot/Phase I Study of Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Lead sponsor
Charlie Wang, MD, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
September 1, 2023
Completion date
September 30, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningioma